Method and intravascular stent for reducing complications after implantation of an intravascular stent
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
May 7, 2002
Grant Date -
N/A
app pub date -
Apr 20, 2001
filing date -
Feb 13, 2001
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
An intravascular stent reduces the risk of restenosis due to stent implantation by using 17beta-estradiol as a vessel healing substance after implantation of an intravascular stent. The 17beta-estradiol coats at least a portion of the surface of the stent and is adhered to the stent with an adhesive layer containing DLC ('diamond-like carbon'). 17beta-estradiol inhibits the growth of smooth muscle cells and stimulates the re-endothelialization after implantation of an intravascular stent.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully